HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The prothrombin G20210A polymorphism in patients with myocardial infarction.

Abstract
To investigate a possible association between the human prothrombin gene G20210A polymorphism and coronary artery thrombosis, we screened 172 consecutive patients with ischaemic heart disease admitted for coronary arteriography. The patients were divided into two groups on the basis of their clinical history and examination of their hospital records: 66 patients with a definite previous myocardial infarction, and 106 with angina-like chest pain but no evidence of myocardial infarction. The overall frequency of the G20210A polymorphism was 0.011, four out of the 172 patients being heterozygous for the mutation. The allelic frequency was 0.015 in the group with myocardial infarction and 0.009 in the group without myocardial infarction (P = 0.622). The results of this study suggest that the single nucleotide polymorphism at position 20210 of the prothrombin gene is unlikely to be a risk factor for coronary thrombosis.
AuthorsE Durante-Mangoni, G J Davies, N Ahmed, G Ruggiero, K Michaelides
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 13 Issue 7 Pg. 603-8 (Oct 2002) ISSN: 0957-5235 [Print] England
PMID12439145 (Publication Type: Journal Article)
Chemical References
  • Prothrombin
Topics
  • Adult
  • Aged
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genotype
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (etiology, genetics)
  • Myocardial Ischemia
  • Polymorphism, Single Nucleotide
  • Prothrombin (genetics)
  • Thrombosis (etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: